115 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 19051398 | METHOD OF INCREASING THE FUNCTION OF AN AAV VECTOR | HIBBERT, CATHERINE S | 1658 | Non-Final OA | Feb 12, 2025 |
| 18904575 | Compositions and Methods for Targeting Lipid Nanoparticle Therapeutics to Stem Cells | WESTERBERG, NISSA M | 1618 | Non-Final OA | Oct 02, 2024 |
| 18720823 | COMPUTER-IMPLEMENTED METHODS AND ASSOCIATED SYSTEMS FOR DETECTING MALIGNANCY | JACOB, OOMMEN | 3797 | Non-Final OA | Jun 17, 2024 |
| 18625699 | METHODS FOR USING ENRICHED EXOSOMES AS A PLATFORM FOR MONITORING ORGAN STATUS | JUEDES, AMY E | 1644 | Final Rejection | Apr 03, 2024 |
| 18596876 | ELECTRONICALLY CONTROLLED MICROSCALE OPTICAL RESONATOR | DUNNING, RYAN S | 2872 | Non-Final OA | Mar 06, 2024 |
| 18431638 | COMPOSITIONS AND METHODS OF ENHANCING ANTI-TUMOR RESPONSE USING HYBRID NEUTROPHILS | PAPCIAK, SHARON M | 1657 | Non-Final OA | Feb 02, 2024 |
| 18392854 | COMPOSITIONS COMPRISING A LECITHIN CHOLESTEROL ACYLTRANSFERASE VARIANT AND USES THEREOF | GROOMS, TIFFANY NICOLE | 1637 | Non-Final OA | Dec 21, 2023 |
| 18572717 | Visual Determination of Sleep States | HULBERT, AMANDA K | 3792 | Non-Final OA | Dec 20, 2023 |
| 18542382 | METHOD FOR TESTING AND SCREENING P38 MAP KINASE MODIFIERS | EMCH, GREGORY S | 1678 | Non-Final OA | Dec 15, 2023 |
| 18570153 | MATERIAL DEPOSITION ONTO AND RECOVERY FROM SURFACES VIA CONTACTLESS, REVERSIBLE DROPLET WETTING/DE-WETTING BY DIELECTRIC CHARGE INJECTION | SUN, CAITLYN MINGYUN | 1795 | Non-Final OA | Dec 14, 2023 |
| 18563707 | MONITORING OF UPPER LIMB MOVEMENTS TO DETECT STROKE | TOTH, KAREN E | 3791 | Non-Final OA | Nov 22, 2023 |
| 18560153 | COMPOSITIONS AND METHODS FOR DEBULKING VIRUS OR MICROORGANISM LOAD IN THE ORAL CAVITY | MOAZZAMI, NAGHMEH NINA | 1652 | Non-Final OA | Nov 10, 2023 |
| 18504261 | GENE THERAPY FOR OCULAR DISORDERS | ZHU, JIANJIAN | 1631 | Final Rejection | Nov 08, 2023 |
| 18494872 | SYSTEMS AND METHODS FOR ORTHOGONAL INTRAVENTRICULAR ACCESS | KIM, SUN U | 1777 | Non-Final OA | Oct 26, 2023 |
| 18381215 | CD19 BINDERS, CAR-T CONSTRUCTS COMPRISING THE SAME, AND METHODS OF USING THE SAME | EDGINGTONGIORDANO, FRANCESCA | 1643 | Non-Final OA | Oct 18, 2023 |
| 18485352 | COMPOSITIONS USEFUL FOR TREATING SPINAL AND BULBAR MUSCULAR ATROPHY (SBMA) | HUDSON, AMY ROSE | 1636 | Non-Final OA | Oct 12, 2023 |
| 18483862 | Nanoparticle Ink Based Patterning Of Inorganic Materials | YOUNG, WILLIAM D | 1761 | Non-Final OA | Oct 10, 2023 |
| 18368130 | Rat models for CMT2A that develop a progressive neuropathy | LEONARD, ARTHUR S | 1631 | Non-Final OA | Sep 14, 2023 |
| 18462149 | Compositions and Methods for Treating Heart Disease via Redirected T Cell Immunotherapies | WEN, SHARON X | 1641 | Final Rejection | Sep 06, 2023 |
| 18548481 | TARGETING T REGULATORY CELLS TO ISLET CELLS TO STALL OR REVERSE TYPE 1 DIABETES | LEE, YIE CHIA | 1642 | Non-Final OA | Aug 30, 2023 |
| 18365318 | Magnetic Separation Filters And Microfluidic Devices Using Magnetic Separation Filters | GERIDO, DWAN A | 1797 | Non-Final OA | Aug 04, 2023 |
| 18351151 | BIOMARKERS PREDICTIVE OF CYTOKINE RELEASE SYNDROME | HALVORSON, MARK | 1646 | Final Rejection | Jul 12, 2023 |
| 18260786 | COMPOSITIONS FOR TREATING FRIEDREICH'S ATAXIA | MIANO, JOSEPH PAUL | 1631 | Non-Final OA | Jul 09, 2023 |
| 18343840 | DEVICE FOR CARDIAC IMAGING AND EPICARDIAL ABLATION AND METHODS OF USE THEREOF | LANGHALS, RENEE C | 3797 | Non-Final OA | Jun 29, 2023 |
| 18332150 | USE OF CART19 TO DEPLETE NORMAL B CELLS TO INDUCE TOLERANCE | CHANDRA, GYAN | 1674 | Non-Final OA | Jun 09, 2023 |
| 18255398 | ENGINEERING OF ORGANOID CULTURE FOR ENHANCED ORGANOGENESIS IN A DISH | FISHER, BRITTANY I | 1796 | Non-Final OA | Jun 01, 2023 |
| 18255154 | NOVEL COMPOSITIONS WITH TISSUE-SPECIFIC TARGETING MOTIFS AND COMPOSITIONS CONTAINING SAME | BARRERA, IMMACULADA | 1671 | Non-Final OA | May 31, 2023 |
| 18254893 | COMPOSITIONS AND USES THEREOF FOR TREATMENT OF ANGELMAN SYNDROME | YU, DAVID TUYANG | 1635 | Non-Final OA | May 30, 2023 |
| 18253919 | PMO-BASED UTROPHIN::LET-7C MIRNA SITE BLOCKING OLIGONUCLEOTIDES (SBOS) FOR TREATING DUCHENNE MUSCULAR DYSTROPHY (DMD) | ALLEN, SARAH ELIZABETH | 1637 | Non-Final OA | May 23, 2023 |
| 18309370 | CELLS EXPRESSING MULTIPLE CHIMERIC ANTIGEN RECEPTOR (CAR) MOLECULES AND USES THEREFORE | GRABER, JAMES J | 1631 | Final Rejection | Apr 28, 2023 |
| 18304843 | Use of CD2/5/7 Knock-Out Anti-CD2/5/7 Chimeric Antigen Receptor T cells Against T Cell Lymphomas and Leukemias | KELLY, ROBERT M | 1638 | Non-Final OA | Apr 21, 2023 |
| 18302111 | SYSTEMS AND METHODS FOR EX VIVO PERFUSION OF VERTEBRATE TISSUE | KOSAR, AARON J | 1655 | Non-Final OA | Apr 18, 2023 |
| 18297141 | MECHANICAL MESH FIXATION DEVICE AND CURVILINEAR TACK SYSTEM | BACHMAN, LINDSEY MICHELE | 3771 | Non-Final OA | Apr 07, 2023 |
| 18296061 | Hyperactive and hmC Dominant TET Enzymes | PAK, YONG D | 1652 | Final Rejection | Apr 05, 2023 |
| 18246872 | COMPOSITIONS AND METHODS FOR TREATMENT OF FABRY DISEASE | VIJAYARAGHAVAN, JAGAMYA NMN | 1633 | Non-Final OA | Mar 28, 2023 |
| 18187131 | Nanocomposite Films And Methods For Producing The Same | REDDY, KARUNA P | 1764 | Non-Final OA | Mar 21, 2023 |
| 18042726 | VIRAL VECTORS ENCODING GLP-1 RECEPTOR AGONIST FUSIONS AND USES THEREOF IN TREATING METABOLIC DISEASES | HUMPHRIES, NICHOLAS ADAM | 1631 | Non-Final OA | Feb 23, 2023 |
| 18042729 | VIRAL VECTOR ENCODING GLP-1 RECEPTOR AGONIST FUSIONS AND USES THEREOF IN TREATING METABOLIC DISEASES IN FELINES | RAVINDRA, KRISHNA NUGGEHALLI | 1636 | Non-Final OA | Feb 23, 2023 |
| 18112763 | METHODS, SYSTEMS, AND COMPUTER READABLE MEDIA FOR MACHINE LEARNING OF MULTIPLE TASKS | MAUNI, HUMAIRA ZAHIN | 2141 | Final Rejection | Feb 22, 2023 |
| 18042092 | TARGETING CARTILAGE EGFR PATHWAY FOR OSTEOARTHRITIS TREATMENT | LEE, SIN J | 1613 | Non-Final OA | Feb 17, 2023 |
| 18040971 | RECOMBINANT ADENO-ASSOCIATED VIRUS FOR TREATMENT OF GRN-ASSOCIATED ADULT-ONSET NEURODEGENERATION | THUESON, HANNA MARIE | 1638 | Non-Final OA | Feb 07, 2023 |
| 18006900 | CANINE AND FELINE INDUCIBLE EXPRESSION CONSTRUCTS FOR GENE THERAPY APPLICATIONS | O'NEILL, MARISOL ANN | 1633 | Non-Final OA | Jan 26, 2023 |
| 18002681 | COMPOSITIONS AND METHODS OF USING A PLA2-RESPONSIVE DRUG DELIVERY SYSTEM | MEJIAS, SAMANTHA LEE | 1618 | Final Rejection | Dec 21, 2022 |
| 18061633 | GENE THERAPY FOR OCULAR DISORDERS | HILL, KEVIN KAI | 1638 | Final Rejection | Dec 05, 2022 |
| 18000644 | Compounds and Methods for Treating, Ameliorating, or Preventing Herpes Ocular Keratitis | MIKNIS, ZACHARY J | 1658 | Non-Final OA | Dec 02, 2022 |
| 17928170 | Compositions and Methods for Detecting Respiratory Viruses Including Coronaviruses | BAUSCH, SARAE L | 1699 | Non-Final OA | Nov 28, 2022 |
| 18056562 | Polymer Blends Having Improved Ion Conductivity, Devices, and Methods | CULLEN, SEAN P | 1725 | Non-Final OA | Nov 17, 2022 |
| 17998330 | COMPOSITIONS USEFUL IN TREATMENT OF KRABBE DISEASE | RIGA, MICHAEL ANGELO | 1634 | Final Rejection | Nov 09, 2022 |
| 17982147 | PREDICTION OF CARDIAC REJECTION VIA MACHINE LEARNING DERIVED FEATURES FROM DIGITAL ENDOMYOCARDIAL BIOPSY IMAGES | WALLACE, JOHN R | 2682 | Final Rejection | Nov 07, 2022 |
| 18052645 | Anisotropic Pattern Transfer Via Colloidal Lithography | RUMMEL, IAN A | 1785 | Final Rejection | Nov 04, 2022 |
| 17997742 | METHODS FOR DETECTION OF PATHOGENIC INFECTIONS USING RED BLOOD CELL-CONTAINING PATIENT SAMPLES | KINSEY WHITE, NICOLE ERIN | 1672 | Non-Final OA | Nov 02, 2022 |
| 18051624 | Manufacturing Of Heterostructured Polymer-Infiltrated Nanoparticle Films Via Capillary Rise Infiltration And Their Applications | LE, HOA T | 1788 | Non-Final OA | Nov 01, 2022 |
| 17997110 | COMPOSITIONS AND METHODS FOR REDUCING NUCLEASE EXPRESSION AND OFF-TARGET ACTIVITY USING A PROMOTER WITH LOW TRANSCRIPTIONAL ACTIVITY | SPENCER, ANDREA LYNNE MORRIS | 1631 | Non-Final OA | Oct 25, 2022 |
| 17972105 | MACHINE LEARNING SYSTEMS USING ELECTRONIC HEALTH RECORD DATA AND PATIENT-REPORTED OUTCOMES | HANKS, BENJAMIN L | 3684 | Final Rejection | Oct 24, 2022 |
| 17937897 | METHODS FOR USING EXTRACELLULAR MICROVESICLES WITH SYNCYTIOTROPHOBLAST MARKERS TO DIAGNOSE PREECLAMPSIA | BORGEEST, CHRISTINA M | 1675 | Final Rejection | Oct 04, 2022 |
| 17937488 | PHOSPHOGLYCERATE KINASE 1 (PGK) PROMOTERS AND METHODS OF USE FOR EXPRESSING CHIMERIC ANTIGEN RECEPTOR | ZHU, JIANJIAN | 1631 | Non-Final OA | Oct 03, 2022 |
| 17995194 | FACTOR B INHIBITORS AND USES THEREOF | DABKOWSKI, ERINNE R | 1654 | Final Rejection | Sep 30, 2022 |
| 17936654 | METHOD OF TREATING OR AMELIORATING CANCERS DRIVEN BY RECEPTOR TYROSINE KINASE FUSION ONCOGENES, AND COMPOSITIONS FOR THE SAME | ROBINSON, MIKHAIL O'DONNEL | 1627 | Non-Final OA | Sep 29, 2022 |
| 17951985 | ANALYSIS OF PLEURAL LINES FOR THE DIAGNOSIS OF LUNG CONDITIONS | OSINSKI, MICHAEL S | 2674 | Non-Final OA | Sep 23, 2022 |
| 17906792 | In vivo targeting of CD4+-T cells for mRNA therapeutics | HUYNH, PHUONG N | 1641 | Non-Final OA | Sep 20, 2022 |
| 17949072 | Lyotropic Gyroid Mesophase Compositions, Polymer Compositions Comprising the Same, Methods of Preparation Thereof, and Methods of Using the Same | MCCLENDON, SANZA L | 1765 | Non-Final OA | Sep 20, 2022 |
| 17822533 | Methods and Compositions for Treatment of Disorders and Diseases Involving RDH12 | SHUKLA, RAM R | 1635 | Non-Final OA | Aug 26, 2022 |
| 17905129 | METHODS OF USING A MULTI-ANALYTE APPROACH FOR DIAGNOSIS AND STAGING A DISEASE | HANEY, AMANDA MARIE | 1682 | Non-Final OA | Aug 26, 2022 |
| 17801959 | TISSUE CULTURE MEDIA FOR SURVIVAL AND ENGRAFTMENT OF HUMAN PANCREATIC ISLETS | TICHY, JENNIFER M.H. | 1653 | Final Rejection | Aug 24, 2022 |
| 17904899 | TREATING AUTOSOMAL DOMINANT BESTROPHINOPATHIES AND METHODS FOR EVALUATING SAME | HILL, KEVIN KAI | 1638 | Non-Final OA | Aug 24, 2022 |
| 17885243 | SYSTEM ARCHITECTURES FOR BIG DATA PROCESSING | CAO, DIEM K | 2196 | Non-Final OA | Aug 10, 2022 |
| 17759905 | COMPOSITIONS USEFUL FOR TREATING GM1 GANGLIOSIDOSIS | LEONARD, ARTHUR S | 1631 | Non-Final OA | Aug 01, 2022 |
| 17759679 | COMPOSITIONS AND METHODS OF T CELL RECEPTOR VB FAMILY MEMBER TARGETING FOR THE TREATMENT OF T CELL ASSOCIATED DISEASE | YAO, LEI | 1642 | Non-Final OA | Jul 28, 2022 |
| 17871702 | PROGRAMMABLE ENZYME-ASSISTED SELECTIVE EXPONENTIAL AMPLIFICATION FOR SENSITIVE DETECTION OF RARE MUTANT ALLELES | LU, FRANK WEI MIN | 1683 | Final Rejection | Jul 22, 2022 |
| 17786147 | COMPOSITIONS AND METHODS FOR HEMOGLOBIN PRODUCTION | PERSONS, JENNA L | 1637 | Final Rejection | Jun 16, 2022 |
| 17784645 | High Performance Platform for Combinatorial Genetic Screening | FLINDERS, JEREMY C | 1684 | Non-Final OA | Jun 11, 2022 |
| 17781945 | NANOPARTICLE COMPOSITIONS AND METHODS OF USE | REDDIG, PETER J | 1646 | Final Rejection | Jun 02, 2022 |
| 17748983 | SPYCATCHER AND SPYTAG: UNIVERSAL IMMUNE RECEPTORS FOR T CELLS | RAHMAN, MASUDUR | 1633 | Non-Final OA | May 19, 2022 |
| 17778061 | Anti-Alpha-Synuclein Monoclonal Antibodies, and Methods Using Same | CHERNYSHEV, OLGA N | 1675 | Final Rejection | May 19, 2022 |
| 17772606 | NON-INVASIVE CEREBRAL MONITORING AND CEREBRAL METRIC-BASED GUIDANCE FOR MEDICAL PROCEDURES | BIANCAMANO, ALYSSA N | 3715 | Final Rejection | Apr 28, 2022 |
| 17769893 | Lipid Nanoparticles and Formulations Thereof for CAR mRNA Delivery | PIHONAK, SARAH | 1627 | Non-Final OA | Apr 18, 2022 |
| 17718922 | ENZYMATIC TARGETING CARIOGENIC BACTERIAL-FUNGAL BIOFILM INTERACTION | ROBERTS, LEZAH | 1612 | Non-Final OA | Apr 12, 2022 |
| 17656660 | TERRITORY MAPPING IN PSEUDO-CONTINUOUS ARTERIAL SPIN LABELING | MERRIAM, AARON ROGERS | 3791 | Final Rejection | Mar 28, 2022 |
| 17689867 | Epigenomic editing and reactivation of targets for the treatment of Fragile X syndrome | ESSEX, LAURA ANN | 1675 | Non-Final OA | Mar 08, 2022 |
| 17636950 | UROFLOW MONITORING SYSTEM AND METHOD | MUSTANSIR, ABID A | 3791 | Final Rejection | Feb 21, 2022 |
| 17672438 | COMPOSITIONS AND METHODS FOR INHIBITING BIOFILM DEPOSITION AND PRODUCTION | DABKOWSKI, ERINNE R | 1654 | Non-Final OA | Feb 15, 2022 |
| 17623246 | NTRANASAL DANTROLENE ADMINISTRATION FOR TREATMENT OF ALZHEIMER'S DISEASE | ADLAM, CHANTAL PETA-GAYE | 1622 | Non-Final OA | Dec 28, 2021 |
| 17617193 | METHODS AND SYSTEMS FOR PARTICLE BASED TREATMENT USING MICRODOSIMETRY TECHNIQUES | DRAPEAU, SIMEON PAUL | 2188 | Final Rejection | Dec 07, 2021 |
| 17533071 | RAPID PRODUCTION OF BISPECIFIC ANTIBODIES FROM OFF-THE-SHELF IGGS WITH HIGH YIELD AND PURITY | HUYNH, PHUONG N | 1641 | Final Rejection | Nov 22, 2021 |
| 17610334 | INSTRINSICALLY LUBRICATING DRUG-LOADED HYDROGELS FOR USE AS PROPHYLACTIC MEDICAL DEVICES | RONEY, CELESTE A | 1612 | Non-Final OA | Nov 10, 2021 |
| 17607837 | MICRO-RNA SITE BLOCKING OLIGONUCLEOTIDES FOR THE TREATMENT OF EPILEPTIC ENCEPHALOPATHY AND NEURODEVELOPMENTAL DISORDERS | SULLIVAN, STEPHANIE LAUREN | 1635 | Non-Final OA | Oct 29, 2021 |
| 17504500 | GLP-1R AGONIST REDUCES RETINAL INFLAMMATION AND NEURON DEATH SECONDARY TO OCULAR HYPERTENSION | BRADLEY, CHRISTINA | 1654 | Final Rejection | Oct 18, 2021 |
| 17602949 | Compositions and Methods Comprising a High Affinity Chimeric Antigen Receptor (CAR) with Cross-Reactivity to Clinically-Relevant EGFR Mutated Proteins | EDGINGTONGIORDANO, FRANCESCA | 1643 | Final Rejection | Oct 11, 2021 |
| 17602277 | METHODS AND COMPOSITIONS FOR PROGRAMMING T CELL DIFFERENTIATION AND ENHANCING T CELL PROLIFERATION | WESTON, ALYSSA G | 1633 | Non-Final OA | Oct 07, 2021 |
| 17601581 | COMPOSITIONS AND METHODS FOR IN UTERO GENE EDITING FOR MONOGENIC LUNG DISEASE | BATES, KEENAN ALEXANDER | 1631 | Non-Final OA | Oct 05, 2021 |
| 17435365 | ADENO-ASSOCIATED VIRUSES AND THEIR USES FOR INNER EAR THERAPY | SULLIVAN, STEPHANIE LAUREN | 1635 | Final Rejection | Aug 31, 2021 |
| 17434894 | METHODS FOR TREATING BLADDER AND URETHRA DYSFUNCTION AND DISEASE | LEE, CHIHYI NMN | 1628 | Final Rejection | Aug 30, 2021 |
| 17433195 | COMPOSITIONS USEFUL IN TREATMENT OF KRABBE DISEASE | RIGA, MICHAEL ANGELO | 1634 | Non-Final OA | Aug 23, 2021 |
| 17380486 | Large Scale Microdroplet Generation Apparatus And Methods Of Manufacturing Thereof | MUI, CHRISTINE T | 1797 | Final Rejection | Jul 20, 2021 |
| 17373485 | NOVEL AAV8 MUTANT CAPSIDS AND COMPOSITIONS CONTAINING SAME | MONTANARI, DAVID A | 1632 | Non-Final OA | Jul 12, 2021 |
| 17356146 | IN VIVO DETECTION OF EGFR MUTATION IN GLIOBLASTOMA VIA MRI SIGNATURE CONSISTENT WITH DEEP PERITUMORAL INFILTRATION | SCHULTZHAUS, JANNA NICOLE | 1685 | Final Rejection | Jun 23, 2021 |
| 17416311 | ADENO-ASSOCIATED VIRUSES AND THEIR USES FOR INNER EAR THERAPY | CONNORS, ALEXANDRA F | 1634 | Final Rejection | Jun 18, 2021 |
| 17298599 | AMPA RECEPTOR ANTAGONISTS SPECIFIC FOR CALCIUM PERMEABLE AMPA RECEPTORS AND METHODS OF TREATMENT THEREWITH | COLEMAN, BRENDA LIBBY | 1624 | Non-Final OA | May 31, 2021 |
| 17294401 | COMPOSITIONS AND METHODS FOR THE CYTOPLASMIC DELIVERY OF ANTIBODIES AND OTHER PROTEINS | AEDER, SEAN E | 1642 | Non-Final OA | May 15, 2021 |
| 17291657 | HEALING AND MORPHOGENESIS OF STRUCTURAL METAL FOAMS AND OTHER MATRIX MATERIALS | KEELING, ALEXANDER W | 1795 | Non-Final OA | May 06, 2021 |
| 17313154 | Protein Kinase RNA-Like Endoplasmic Reticulum Kinase (PERK) Inhibitors for Prevention and/or Treatment of Lung Injury and/or Inflammation | VYAS, KEYUR ANILKUMAR | 1637 | Final Rejection | May 06, 2021 |
| 17189970 | MOBILIZED PERIPHERAL BLOOD AS A SOURCE OF MODIFIED IMMUNE CELLS | MIDDLETON, DANAYA L | 1674 | Non-Final OA | Mar 02, 2021 |
| 17097997 | COMPOSITIONS FOR DRG-SPECIFIC REDUCTION OF TRANSGENE EXPRESSION | HILL, KEVIN KAI | 1638 | Final Rejection | Nov 13, 2020 |
| 17095370 | MEDICAL DEVICE FOR THE PREVENTION OF THROMBOSIS | LEDERER, SARAH B | 3785 | Final Rejection | Nov 11, 2020 |
| 17079119 | METHODS, SYSTEMS, AND COMPUTER READABLE MEDIA FOR TESTING VISUAL FUNCTION USING VIRTUAL MOBILITY TESTS | JORDAN, DANIEL JEFFERY | 2872 | Final Rejection | Oct 23, 2020 |
| 17047993 | COMPOSITIONS AND METHODS FOR TREATING MELANOMA WITH A CHIMERIC ANTIGEN RECEPTOR | DUFFY, BRADLEY | 1643 | Non-Final OA | Oct 15, 2020 |
| 16980064 | BETA GLUCAN AND CD40 AGONIST COMBINATION IMMUNOTHERAPY | KRISHNAN, GANAPATHY | 1693 | Final Rejection | Sep 11, 2020 |
| 16975541 | NOVEL ADENO-ASSOCIATED VIRUS (AAV) VECTORS, AAV VECTORS HAVING REDUCED CAPSID DEAMIDATION AND USES THEREFOR | WANG, RUIXUE | 1672 | Non-Final OA | Aug 25, 2020 |
| 16971995 | METHODS AND COMPOSITIONS COMPRISING CART AND A SMAC MIMETIC | CONNORS, ALEXANDRA F | 1634 | Non-Final OA | Aug 21, 2020 |
| 16870484 | Compositions And Methods For Imaging Immune Cells | SAMALA, JAGADISHWAR RAO | 1618 | Final Rejection | May 08, 2020 |
| 16753634 | Tissue Engineered "Axon Fusion" for Immediate Recovery Following Axon Transection | TICHY, JENNIFER M.H. | 1653 | Non-Final OA | Apr 03, 2020 |
| 16435257 | TREATMENT OF CANCER USING ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR | BRISTOL, LYNN ANNE | 1643 | Final Rejection | Jun 07, 2019 |
| 16317943 | TREATMENT AND PREVENTION OF CYTOKINE RELEASE SYNDROME USING A CHIMERIC ANTIGEN RECEPTOR IN COMBINATION WITH A KINASE INHIBITOR | LU, CHENG | 1642 | Final Rejection | Jan 15, 2019 |
| 16093758 | COMPOSITIONS AND METHODS FOR SELECTIVE PROTEIN EXPRESSION | MARTINEZ, TARA L | 1654 | Non-Final OA | Oct 15, 2018 |
| 15327794 | SUBSET-OPTIMIZED CHIMERIC ANTIGEN RECEPTOR-CONTAINING T-CELLS | POPA, ILEANA | 1633 | Non-Final OA | Jan 20, 2017 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial